---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-082895"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2023-07-21T23:59:59+00:00"
generated_at: "2026-06-13T04:57:35.571655+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# First Wave BioPharma prices $2.1M public offering of stock and warrants at $0.64/unit

## Summary
- Offering includes 3,285,000 shares (or pre-funded warrants) and warrants to buy up to 6,570,000 shares.
- Combined public offering price of $0.64 per share (or pre-funded warrant) and two accompanying warrants.
- Warrants have exercise price of $0.64, immediately exercisable, expire in 5 years.
- Net proceeds approximately $1.8 million; expected closing July 21, 2023.
- Roth Capital Partners acting as exclusive placement agent; proceeds for working capital.

## SEC filing metadata
- accession: 0001104659-23-082895
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2023-07-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/0001104659-23-082895-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/tm2321782d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-082895
- JSON: https://secwatch.observer/filing/0001104659-23-082895.json
- Plain text: https://secwatch.observer/filing/0001104659-23-082895.txt

## Key facts
- Material Agreements
  GridAI Technologies Corp. entered into Placement Agency Agreement with Roth Capital Partners, LLC (effective 2023-07-18).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Roth Capital Partners, LLC
  - Effective: 2023-07-18
  source text: On July 18, 2023, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/0001104659-23-082895-index.htm
- Material Agreements
  GridAI Technologies Corp. entered into Purchase Agreement with certain purchasers valued at approximately $1.8 million (effective 2023-07-18).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain purchasers
  - Value: approximately $1.8 million
  - Effective: 2023-07-18
  source text: ith Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with certain purchasers pursuant to which the Company agreed to sell, in a best efforts public offering (the “Offering”),
  evidence_url: https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/0001104659-23-082895-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.